UK evidence-led drug information
UK Drug Trends Intelligence ↗TD Consultancy ↗
Drug emergency? If someone is unconscious, having a seizure, severely confused or not breathing normally, call 999.
Drug mixture / opioid-containing drinkUK guide

Lean

Lean is not one drug or a standard recipe. The term is commonly used for drinks containing codeine cough medicine, often with a sedating antihistamine such as promethazine, mixed with a soft drink. Contents and strength can differ substantially.

Reviewed 5 August 2026Legal information checked 5 August 2026Responsible organisation TD Consultancy
Unbranded medicine bottle, measuring cup and a plain cup with muted purple liquid representing a codeine-based Lean mixture

Appearance varies. A substance cannot be reliably identified by colour, shape, packaging or an image.

Overview

What is Lean?

Common and street names

purple drank · sizzurp · codeine drink

Drug category

Drug mixture / opioid-containing drink

Forms and appearance

A mixed drink rather than a standard product. Colour, bottle type and flavour do not identify the medicines or strengths used.

How it is commonly used

Lean is swallowed as a drink. The critical question is what medicines and other substances are actually in the mixture, not the slang name used for it.

Brain & body

How Lean affects signalling and behaviour

Codeine is an opioid that is partly converted to morphine in the body. Opioid effects include analgesia, sedation and slowed breathing. Promethazine is a sedating antihistamine, so combining the ingredients can increase impairment and sedation.

Effects & risks

What people may experience — and what can go wrong

Commonly reported effects

  • Sedation and relaxation
  • Pain relief from opioid ingredients
  • Drowsiness and slowed reactions
  • Nausea, itching or constipation

Short-term risks

  • Respiratory depression
  • Loss of consciousness and aspiration
  • Unpredictable effect where ingredients or strengths are unknown
  • Additional medicine toxicity depending on the product used

Longer-term risks

  • Opioid tolerance and dependence
  • Constipation and sleep disruption
  • Increasing dose or frequency as tolerance develops
  • Harms from additional ingredients in repeated high exposure

Mental-health effects

Sedation may be experienced as relief from stress or emotional distress, which can reinforce repeated use. Low mood, reduced motivation and reliance on the mixture to regulate sleep or emotions can complicate change.

Dependence, tolerance & withdrawal

Repeated use can change the pattern

Regular opioid exposure can produce tolerance and physical dependence. Withdrawal may include aches, sweating, gastrointestinal symptoms, anxiety and insomnia. Assessment should consider every ingredient rather than treating Lean as a single substance.

Mixing drugs

Interaction risks to know

01

Lean + alcohol can increase sedation and respiratory depression.

02

Lean + benzodiazepines, pregabalin/gabapentin, GHB/GBL or other sedatives can substantially increase risk.

03

Other opioid medicines add to opioid exposure.

No combination is labelled safe.

The absence of a recorded interaction does not mean that a combination is safe. Strength, dose, health, tolerance, contamination and other substances can alter risk.

Check another combination

Harm reduction

Practical ways to reduce risk

1

Do not assume two Lean preparations contain the same drugs or strength.

2

Avoid combining opioid-containing mixtures with alcohol, benzodiazepines or other sedatives.

3

Know the signs of opioid overdose and where to obtain naloxone.

4

Check medicine labels carefully: extra active ingredients can create additional risks.

Harm reduction can reduce some risks; it cannot make an unregulated drug, dose or combination risk-free.

Emergency

When to call 999

  • Very slow, shallow or stopped breathing
  • Blue, grey or very pale lips/skin
  • Cannot be woken
  • Gurgling, choking or pinpoint pupils alongside reduced consciousness
If in doubt in a suspected drug emergency, call 999 and describe what you can see. Do not wait for certainty about the substance.

Treatment & support

Help does not require one fixed recovery goal

UK drug and alcohol services can assess physical health, mental health, dependence, risk, housing and support needs, then agree a plan with the person. Goals may include immediate harm reduction, stabilisation, reduction or stopping use.

Regular opioid exposure can produce tolerance and physical dependence. Withdrawal may include aches, sweating, gastrointestinal symptoms, anxiety and insomnia. Assessment should consider every ingredient rather than treating Lean as a single substance.

Brief history

How we got here

Codeine-based drinks became associated with music cultures in the southern United States during the late twentieth century, building on earlier syrup-and-drink practices. Online music, video and social media later spread the imagery far beyond its regional origins.

Read the history guide

Key facts & misconceptions

Three useful corrections

01

Lean is not 'just cough syrup'.

02

Purple colour does not identify ingredients or strength.

03

A medicine being available on prescription does not make non-medical mixtures predictable or safe.

Lean (Purple Drank): A Practitioner’s Guide book cover

Explore Lean in greater depth

Lean (Purple Drank): A Practitioner’s Guide

By Tony D'Agostino. A practitioner-focused companion on culture, ingredients, harm reduction and professional response.

Buy on Amazon ↗

Frequently asked questions

Quick answers

What type of drug is Lean?

Lean is described here as drug mixture / opioid-containing drink. Some drugs cross categories, and mixtures may contain more than one drug type.

Can Lean be identified by appearance?

No. Appearance, packaging, a logo or colour cannot reliably establish identity, strength or contamination.

When should I call 999?

Call 999 for a suspected drug emergency, including reduced consciousness, abnormal breathing, seizure, severe chest pain or severe confusion. Very slow, shallow or stopped breathing

Evidence & governance

Sources and review

Responsible organisation: TD Consultancy
Published: 5 August 2026 · Last reviewed: 5 August 2026
Next formal review: February 2027, or earlier if material safety or legal information changes.

Evidence on illicit drug composition and emerging markets can change quickly. Legal status can be compound- and preparation-specific. Links below are prioritised to current official UK guidance.